HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].

Abstract
A 56-year-old man who had previously undergone transurethral resection and intra-arterial chemotherapy for bladder cancer developed irritable bladder, bilateral conjunctivitis and arthritis including the knees, ankles and sacroiliac joints after starting intravesical Calmette-Guerin bacillus (BCG) immunotherapy. These symptoms were in agreement with the features of Reiter syndrome. One month after cessation of the intravesical BCG immunotherapy and initiation of the treatment with a non-steroidal anti-inflammatory drug (NSAID), he was not complaining of symptoms. Reiter syndrome is an uncommon complication after intravesical BCG immunotherapy. Nevertheless, since the prolonged arthritis has a possibility to cause joint deformity, we must pay serious attention to this side effect.
AuthorsMasahiro Shiba, Takahiro Fujii, Hiroshi Takatera
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 49 Issue 10 Pg. 599-601 (Oct 2003) ISSN: 0018-1994 [Print] Japan
PMID14655604 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • BCG Vaccine
Topics
  • Administration, Intravesical
  • Arthritis, Reactive (epidemiology, etiology)
  • BCG Vaccine (administration & dosage, adverse effects)
  • Carcinoma, Transitional Cell (therapy)
  • Humans
  • Immunotherapy
  • Male
  • Middle Aged
  • Urinary Bladder Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: